360 related articles for article (PubMed ID: 28093505)
1. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
2. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
3. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
[TBL] [Abstract][Full Text] [Related]
4. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
6. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
[TBL] [Abstract][Full Text] [Related]
7. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
8. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
9. The molecular genetics of erythropoietic protoporphyria.
Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
[TBL] [Abstract][Full Text] [Related]
10. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
[TBL] [Abstract][Full Text] [Related]
12. Digital PCR (dPCR) analysis reveals that the homozygous c.315-48T>C variant in the FECH gene might cause erythropoietic protoporphyria (EPP).
Brancaleoni V; Granata F; Missineo P; Fustinoni S; Graziadei G; Di Pierro E
Mol Genet Metab; 2018 Aug; 124(4):287-296. PubMed ID: 29941360
[TBL] [Abstract][Full Text] [Related]
13. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
14. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancer.
Kadara H; Nemer G; Safi R; Rebeiz N; Daou L; Delbani D; Btadini W; Abbas O; Tofaili M; Bitar F; Kibbi AG; Shimomura Y; Kurban M
Clin Genet; 2017 Nov; 92(5):495-502. PubMed ID: 28075030
[TBL] [Abstract][Full Text] [Related]
16. Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with erythropoietic protoporphyria.
Parera VE; Koole RH; Minderman G; Edixhoven A; Rossetti MV; Batlle A; de Rooij FW
Mol Med; 2009; 15(11-12):425-31. PubMed ID: 19693296
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of erythropoietic protoporphyria in South Africa.
Parker M; Corrigall AV; Hift RJ; Meissner PN
Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria.
Wiman A; Floderus Y; Harper P
J Hum Genet; 2003; 48(2):70-6. PubMed ID: 12601550
[TBL] [Abstract][Full Text] [Related]
19. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
20. Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
Balwani M; Naik H; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Overbey JR; Wang B; Singal AK; Liu LU; Desnick RJ
JAMA Dermatol; 2017 Aug; 153(8):789-796. PubMed ID: 28614581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
